Log in to search using one of your social media accounts:

Eating more fish 'can alleviate rheumatoid arthritis symptoms'
This study indicates that simple changes, such as increasing the amount of fish in their diets, could have a big impact on making the condition more manageable. Lead author Dr Sara Tedeschi, of the division of rheumatology, immunology and allergy at Brigham and Women's Hospital and Harvard Medical School, said:"If our finding holds up in other studies, it suggests that fish consumption may lower inflammation related to rheumatoid arthritis disease activity. "Fish consumption has been noted to have many beneficial health effects, and our findings may give patients with rheumatoid arthritis a strong reason to i...
Source: Arthritis Research UK - June 21, 2017 Category: Rheumatology Source Type: news

Rheumatoid arthritis treatment: THIS may be a new way to cure painful symptoms
RHEUMATOID arthritis affects more than 400,000 people in the UK, but scientists may have found a new way to treat symptoms. (Source: Daily Express - Health)
Source: Daily Express - Health - June 21, 2017 Category: Consumer Health News Source Type: news

Medical News Today: Rheumatoid arthritis: Regular fish intake may ease symptoms
Eating more than two portions of fish every week was found to reduce disease activity in patients with rheumatoid arthritis, a new study reveals. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 21, 2017 Category: Consumer Health News Tags: Arthritis / Rheumatology Source Type: news

Filgotinib Combined With MTX in Patients With Active RA Filgotinib Combined With MTX in Patients With Active RA
The addition of filgotinib may be an effective option for patients with active rheumatoid arthritis who did not sufficiently respond to methotrexate alone.Annals of the Rheumatic Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 21, 2017 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Fish as Medicine for Rheumatoid Arthritis
Eating fish may help reduce the joint pain and swelling of rheumatoid arthritis, a new study has found. (Source: NYT Health)
Source: NYT Health - June 21, 2017 Category: Consumer Health News Authors: NICHOLAS BAKALAR Tags: Fish and Other Marine Life Rheumatoid Arthritis Joints (Body Part) Methotrexate (Drug) Source Type: news

New gene mutations found in white blood cells in patients with rheumatoid arthritis
(University of Helsinki) Gene mutations accumulating in cells are typical of the development of cancer. Finnish researchers found that a similar accumulation of mutations occurs also in some patients with rheumatoid arthritis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 21, 2017 Category: International Medicine & Public Health Source Type: news

Tocilizumab Triumphs in Methotrexate Combo for RA Tocilizumab Triumphs in Methotrexate Combo for RA
It is not always clear which biologic to add to methotrexate for rheumatoid arthritis, but a new comparison between tocilizumab and a number of TNF inhibitors has some suggestions.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 20, 2017 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Biologics Comparison in Rheumatoid Arthritis Surprises Biologics Comparison in Rheumatoid Arthritis Surprises
A Swedish study had rheumatologists debating the top contenders for second-line therapy in patients with rheumatoid arthritis who do not respond to TNF inhibitor therapy.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 20, 2017 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Rheumatoid and osteoarthritis symptoms - what is the difference between the conditions?
RHEUMATOID arthritis and osteoarthritis are two different types of arthritis which present different symptoms. But few people know the different between the two conditions. (Source: Daily Express - Health)
Source: Daily Express - Health - June 19, 2017 Category: Consumer Health News Source Type: news

Biologic-Naive Respond Better to TNF Combination in RA Biologic-Naive Respond Better to TNF Combination in RA
US clinical practice data confirm that combination therapy with TNF inhibitors improves rheumatoid arthritis response compared with monotherapy; however, treatment history makes a difference.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 16, 2017 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Children exposed to smoke more likely to develop arthritis
Smokers exposed to cigarette smoke during their childhood years increase their risk of developing rheumatoid arthritis, a groundbreaking French study claims. (Source: the Mail online | Health)
Source: the Mail online | Health - June 16, 2017 Category: Consumer Health News Source Type: news

New Safety and Long-Term Efficacy Data from Baricitinib Clinical Trials in Patients with Moderate-to-Severe Rheumatoid Arthritis Presented at EULAR 2017
Pooled analysis of eight clinical trials shows no difference in serious infection events compared to placebo Results from long-term extension of Phase 3 studies show treatment with baricitinib slows the progression of joint damage and controls disease a... Biopharmaceuticals Eli Lilly, Incyte , Olumiant, baricitinib, rheumatoid arthritis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 16, 2017 Category: Pharmaceuticals Source Type: news

Excess risk of cardiovascular events in RA patients decreased since start of 21st century
(European League Against Rheumatism) The results of a meta-analysis presented for the first time today at the Annual European Congress of Rheumatology 2017 press conference showed that the excess risk of cardiovascular events in rheumatoid arthritis (RA) patients relative to the general population has decreased since the year 2000. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 16, 2017 Category: International Medicine & Public Health Source Type: news

New study shows for first time link between passive smoking in childhood and rheumatoid arthritis
(European League Against Rheumatism) The results of a study presented today at the Annual European Congress of Rheumatology 2017 press conference confirmed the link between active smoking and the risk of developing rheumatoid arthritis (RA). However, interestingly, it also suggested for the first time that in smokers, exposure to tobacco early in life through passive smoking in childhood significantly increased this risk. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 16, 2017 Category: International Medicine & Public Health Source Type: news

New relapse prediction tool reduces cost of rheumatoid arthritis treatment
(European League Against Rheumatism) The results of a study presented today at the Annual European Congress of Rheumatology 2017 have shown that the combined use of two measurements to accurately predict the risk of relapse in patients with rheumatoid arthritis (RA) allows successful dose reduction (tapering) of their disease modifying anti-rheumatic drugs (DMARDs). This in turn increases the cost-effectiveness of each DMARD treatment. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 16, 2017 Category: International Medicine & Public Health Source Type: news

Janssen reports positive long-term results from Phase III trial of sirukumab for RA
Janssen-Cilag International (Janssen) has reported positive long-term results from the Phase III SIRROUND-T clinical trial of sirukumab to treat patients with rheumatoid arthritis (RA). (Source: Drug Development Technology)
Source: Drug Development Technology - June 15, 2017 Category: Pharmaceuticals Source Type: news

New Biosimilar for Adalimumab in Rheumatoid Arthritis New Biosimilar for Adalimumab in Rheumatoid Arthritis
A large multinational study compares the efficacy and safety of FKB327 biosimilar to adalimumab in active rheumatoid arthritis. But antidrug antibody levels raise questions.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 15, 2017 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Boehringer Ingelheim presents phase III results demonstrating clinical equivalence of adalimumab biosimilar candidate to HUMIRA ®
Boehringer Ingelheim has announced results from the pivotal Phase III VOLTAIRE®-RA(1) study, confirming that its adalimumab biosimilar candidate BI 695501 and HUMIRA®* have similar efficacy, safety and immunogenicity in patients with moderately-to-severely active rheumatoid arthritis. The 24 week results will be presented at the Annual European Congress of Rheumatology (EULAR 2017) in Madrid. (Source: World Pharma News)
Source: World Pharma News - June 15, 2017 Category: Pharmaceuticals Tags: Featured Boehringer Ingelheim Business and Industry Source Type: news

Biological DMARD guidelines associated with a reduced need for knee and hip replacements in RA
(European League Against Rheumatism) The results of a Danish study presented today at the Annual European Congress of Rheumatology 2017 press conference showed that the incidence of total knee replacements carried out on patients with rheumatoid arthritis started to decrease after the introduction of biological Disease-Modifying Anti-Rheumatic Drugs (bDMARDs) to national treatment guidelines. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 15, 2017 Category: International Medicine & Public Health Source Type: news

Rheumatoid arthritis: Being overweight might NOT be a risk factor in men
Rheumatoid arthritis affects one per cent of the UK population, and symptoms include joint pain, stiffness and swelling. (Source: Daily Express - Health)
Source: Daily Express - Health - June 14, 2017 Category: Consumer Health News Source Type: news

Body fat and waist size linked to increased risk of developing rheumatoid arthritis in women
(European League Against Rheumatism) Madrid, Spain, June 14, 2017: The results of a population study presented today at the Annual European Congress of Rheumatology (EULAR) 2017 showed that, in women, being overweight or obese, as defined by body mass index (BMI ), abdominal obesity and a higher body fat percentage was associated with a higher risk of developing rheumatoid arthritis (RA) (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 14, 2017 Category: International Medicine & Public Health Source Type: news

Diet to cure arthritis: Eating THIS part of the Mediterranean diet could suppress symptoms
RHEUMATOID arthritis is a serious and disabling autoimmune disease in which the immune system mistakenly attacks and destroys healthy body tissue. Symptoms can include joint pain and tiredness. (Source: Daily Express - Health)
Source: Daily Express - Health - June 13, 2017 Category: Consumer Health News Source Type: news

Medical News Today: Arthritis drug could cure severe heart condition
Researchers find that drug being tested for the treatment of rheumatoid arthritis may also hold the key to preventing aortic valve stenosis. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 13, 2017 Category: Consumer Health News Tags: Heart Disease Source Type: news

Tight RA Control Via Tele-health Noninferior to Conventional Clinic Visits Tight RA Control Via Tele-health Noninferior to Conventional Clinic Visits
Tele-health follow-up based on patient-reported outcome (PRO) is noninferior to conventional outpatient care for tight control of disease activity in rheumatoid arthritis (RA) patients with low disease activity or remission, new findings show.Reuters Health Information (Source: Medscape Orthopaedics Headlines)
Source: Medscape Orthopaedics Headlines - June 12, 2017 Category: Orthopaedics Tags: Family Medicine/Primary Care News Source Type: news

Truxima (rituximab) for the Treatment of Cancer
ruxima ™ (rituximab) is the first biosimilar monoclonal antibody (mAb) approved for the treatment of haematological cancers, including diffuse large B-cell lymphoma, follicular lymphoma, chronic lymphocytic leukaemia, and rheumatoid arthritis, as well… (Source: Drug Development Technology)
Source: Drug Development Technology - June 8, 2017 Category: Pharmaceuticals Source Type: news

Here ’s how vagus nerve stimulation is getting better
A vagus nerve implant with 2 electrodes – one to apply desired stimulation going down into the body, the other to block unwanted stimulation going up to the brain. [Image from Georgia Tech/Rob Felt]Georgia Institute of Technology researchers have reported success targeting vagus nerve stimulation – providing hope for people with a host of inflammatory diseases including rheumatoid arthritis, irritable bowel syndrome and Crohn’s disease. Researchers implanted a pacemaker-like device into rats and showed that it could electrically stimulate the vagus nerve while simultaneously preventing unwanted nerve acti...
Source: Mass Device - June 8, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: Implants Research & Development Georgia Institute of Technology MedTech stimulation vagus nerve Source Type: news

AbbVie's Rheumatoid Arthritis Drug Succeeds in Late-stage Trial AbbVie's Rheumatoid Arthritis Drug Succeeds in Late-stage Trial
U.S. drugmaker AbbVie Inc said on Wednesday late-stage data showed its rheumatoid arthritis drug performed better than a placebo in reducing symptoms in moderate-to-severe patients who have not adequately responded to standard treatments.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - June 8, 2017 Category: Surgery Tags: Rheumatology News Source Type: news

New drug could fight rheumatoid arthritis symptoms - ‘exciting’ results for patients
RHEUMATOID arthritis patients are a step closer to a new, effective treatment following a breakthrough study. Symptoms of rheumatoid arthritis can be painful but experts have hailed the results as 'exciting'. (Source: Daily Express - Health)
Source: Daily Express - Health - June 8, 2017 Category: Consumer Health News Source Type: news

Will Rheumatoid Arthritis Nodules Go Away?
Title: Will Rheumatoid Arthritis Nodules Go Away?Category: Doctor's& Expert's views on SymptomsCreated: 6/8/2017 12:00:00 AMLast Editorial Review: 6/8/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - June 8, 2017 Category: Rheumatology Source Type: news

What's the Rheumatoid Arthritis Prognosis?
Title: What's the Rheumatoid Arthritis Prognosis?Category: Doctor's& Expert's views on SymptomsCreated: 6/8/2017 12:00:00 AMLast Editorial Review: 6/8/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - June 8, 2017 Category: Rheumatology Source Type: news

AbbVie's rheumatoid arthritis drug succeeds in trial
(Reuters) - AbbVie Inc said on Wednesday its oral rheumatoid arthritis drug succeeded in a late-stage study on patients who had not adequately responded to standard treatments. (Source: Reuters: Health)
Source: Reuters: Health - June 7, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

AbbVie's rheumatoid arthritis drug succeeds in late-stage trial
(Reuters) - U.S. drugmaker AbbVie Inc said on Wednesday its drug to treat moderate-to-severe rheumatoid arthritis met the main goal in a late-stage study. (Source: Reuters: Health)
Source: Reuters: Health - June 7, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Arthritis symptoms - painful joints could be a sign of THIS life-threatening condition
ARTHRITIS - either osteoarthritis or rheumatoid arthritis - causes pain the in joints, including the hips, wrists, ankles and knees. (Source: Daily Express - Health)
Source: Daily Express - Health - June 7, 2017 Category: Consumer Health News Source Type: news

What Are Home Remedies for Rheumatoid Arthritis?
Title: What Are Home Remedies for Rheumatoid Arthritis?Category: Doctor's& Expert's views on SymptomsCreated: 6/7/2017 12:00:00 AMLast Editorial Review: 6/7/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - June 7, 2017 Category: Rheumatology Source Type: news

Putting Disability Benefits on the Election agenda
Volunteers, campaigners and staff from Arthritis Research UK attended the National Disability Hustings this week hosted by a consortium of charities working to support people with disabilities.Over 150 disabled people gathered in Church House to hear from, and question, representatives from the political parties. The panel was made up of Penny Mordaunt, most recent Minister for Disabled People representing the Conservatives, Kate Green, former Shadow Minister for Disabled People for Labour, and Baroness Brinton, a Liberal Democrat Peer and former health spokesperson. Baroness Brinton was also the first wheelchair user to h...
Source: Arthritis Research UK - June 6, 2017 Category: Rheumatology Source Type: news

Risk Factors of Cervical Spine Instabilities in RA Risk Factors of Cervical Spine Instabilities in RA
A study explores the prognostic factors that may identify the risk of cervical spine instabilities among patients with rheumatoid arthritis.Spine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 5, 2017 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Kevzara (sarilumab) for the Treatment of Rheumatoid Arthritis
Kevzara ® (sarilumab) is a human monoclonal antibody indicated for the treatment of adult patients with moderate to severely active rheumatoid arthritis (RA). (Source: Drug Development Technology)
Source: Drug Development Technology - June 4, 2017 Category: Pharmaceuticals Source Type: news

9 Reasons To Drink Water That Have Nothing To Do With Being Thirsty
Exactly how much water people need to drink each day to stay hydrated is a subject of debate. You’ve likely heard that you need at least six to eight glasses a day, but the real figure depends on other factors. How much activity you get, the climate you live in and how much water you get from sources like fruits and vegetables all matters. The good news is that as long as you make water your main beverage, drink when you’re thirsty and consume it with meals, you don’t need to get caught up tallying glasses, according to the U.S. Centers for Disease Control and Prevention. But keeping properly hydrate...
Source: Healthy Living - The Huffington Post - June 2, 2017 Category: Consumer Health News Source Type: news

Poor Prognostic Factors Guiding Treatment Decisions in RA Poor Prognostic Factors Guiding Treatment Decisions in RA
Prognostic factors are used to guide treatment strategies for rheumatoid arthritis -- but how are these factors currently defined?Arthritis Research & Therapy (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 1, 2017 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

In Rheumatoid Arthritis, Adding a Biologic Agent Before Trying Triple Therapy Likely Not Cost-Effective (FREE)
By Amy Orciari Herman Edited by David G. Fairchild, MD, MPH For patients with active rheumatoid arthritis despite methotrexate therapy, adding a biologic agent (e.g., etanercept) before trying triple therapy would lead to substantial cost increases without much … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - May 30, 2017 Category: Primary Care Source Type: news

Falls and their association with physical tests, functional capacity, clinical and demographic factors in patients with rheumatoid arthritis - Louren ço MA, Roma I, Assis MR.
OBJECTIVE: To evaluate the occurrence of falls reported by rheumatoid arthritis patients and its relation to disease activity, functional capacity and physical fitness. MATERIALS AND METHODS: A cross-sectional study constituted by a sample of 97 rh... (Source: SafetyLit)
Source: SafetyLit - May 29, 2017 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Biologics before triple therapy not cost effective for rheumatoid arthritis
(American College of Physicians) Stepping up to biologic therapy when methotrexate monotherapy fails offers minimal incremental benefit over using a combination of drugs known as triple therapy, yet incurs large costs for treating rheumatoid arthritis (RA). Results of a comprehensive cost-effectiveness analysis suggest that patients who have RA and no contraindications to triple therapy should use it prior to a biologic as the next regimen. The study is published in Annals of Internal Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 29, 2017 Category: International Medicine & Public Health Source Type: news

FDA approves Sanofi and Regeneron ’s Kevzara for adult rheumatoid arthritis
Sanofi and Regeneron Pharmaceuticals ’ drug Kevzara (sarilumab) has received the US Food and Drug Administration (FDA) approval to treat adult patients affected with moderately to severely active rheumatoid arthritis (RA). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - May 23, 2017 Category: Pharmaceuticals Source Type: news

UK watchdog accuses Merck of restricting biosimilar competition
Britain’s Competition and Markets Authority accused Merck‘s (NYSE:MRK) European unit, Merck Sharp & Dohme, of conducting an unfair discount scheme that it said was designed to restrict competition from biosimilar copies of the company’s drug, Remicade. Remicade is an antibody drug used to treat rheumatoid arthritis, ulcerative colitis and Chron’s disease. It was the 1st antibody drug to face competition from copycat versions in the European markets. Biosimilar drugmakers, including South Korea’s Celltrion, have launched discounted products that are “similar” enough to Remicade ...
Source: Mass Device - May 23, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Pharmaceuticals Regulatory/Compliance Wall Street Beat Merck Source Type: news

FDA Approves Sarilumab for Adults With Rheumatoid Arthritis FDA Approves Sarilumab for Adults With Rheumatoid Arthritis
The drug will be marketed in self-injectible prefilled syringes and pens to be used once every 2 weeks. It offers an alternative to drugs such as methotrexate.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 23, 2017 Category: Consumer Health News Tags: Rheumatology News Alert Source Type: news

FDA Gives Nod to Sarilumab for Rheumatoid Arthritis
(MedPage Today) -- Can be used as monotherapy or with methotrexate for active RA (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - May 23, 2017 Category: American Health Source Type: news

Medical abbreviations: A language WNL
Patient A+0x3, ST with PVCs and PACs.  Lungs clear bilaterally with POX 98% on RA and SOB on exertion,  PPP, NPO after midnight. PERRLA. Normal BSx4 quadrants. Abd dressing C/D/I C scant amt of serosang drainage. MAE, SBA, and OOB as tolerated. BP WNL. NS infusing @75 ml/hr through RTL PICC, F/P. Reading medical charts can be confusing to those not familiar with medical terminology and abbreviations.  The paragraph above can be frustrating for a new monitor who already had to learn research terminology but now they have to develop their medical terminology skillset.  Let’s take a look at a few com...
Source: Mass Device - May 23, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: Blog IMARC Source Type: news

Sanofi and Regeneron announce FDA Approval of Kevzara ® (sarilumab) for the treatment of moderately to severely active rheumatoid arthritis in adult patients
Sanofi and Regeneron Pharmaceuticals, Inc. have announced the U.S. Food and Drug Administration (FDA) approval of Kevzara® (sarilumab) for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response or intolerance to one or more disease modifying antirheumatic drugs (DMARDs), such as methotrexate (MTX). (Source: World Pharma News)
Source: World Pharma News - May 23, 2017 Category: Pharmaceuticals Tags: Featured Sanofi Business and Industry Source Type: news

​Sanofi Genzyme takes on world’s top-selling drugs with new approval
With Monday ’s announcement that U.S. regulators have approved a drug for rheumatoid arthritis developed by Sanofi Genzyme and Regeneron Pharmaceuticals, the two drugmakers revealed a tried-and-true strategy to take on the world’s number one and number three best-selling drugs, which also happen to be for t hat same disease: give it a lower price. Cambridge-based Sanofi Genzyme (NYSE: SNY) and Tarrytown, N.Y.-based Regeneron (NYSE: REGN) will market their new drug, which has the generic name of… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - May 23, 2017 Category: Health Management Authors: Don Seiffert Source Type: news

​Sanofi Genzyme takes on world’s top-selling drugs with new approval
With Monday ’s announcement that U.S. regulators have approved a drug for rheumatoid arthritis developed by Sanofi Genzyme and Regeneron Pharmaceuticals, the two drugmakers revealed a tried-and-true strategy to take on the world’s number one and number three best-selling drugs, which also happen to be for t hat same disease: give it a lower price. Cambridge-based Sanofi Genzyme (NYSE: SNY) and Tarrytown, N.Y.-based Regeneron (NYSE: REGN) will market their new drug, which has the generic name of… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 23, 2017 Category: Biotechnology Authors: Don Seiffert Source Type: news